Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host

Parasites and Vectors

Volumn 5, Issue 1, 2012, Pages

  Albers, Anna ^a   Esum, Mathias Eyong ^b,c   Tendongfor, Nicholas ^b,c   Enyong, Peter ^b   Klarmann, Ute ^a   Wanji, Samuel ^b,c   Hoerauf, Achim ^a   Pfarr, Kenneth ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Research Foundation for Tropical Diseases and Environment   (Cameroon)

^c UNIVERSITY OF BUEA   (Cameroon)

Author keywords

development; doxycycline; Onchocerca volvulus; onchocerciasis; Wolbachia

Indexed keywords

DOXYCYCLINE; PLACEBO; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; DNA EXTRACTION; DOUBLE BLIND PROCEDURE; HUMAN; LARVA; LARVAL DEVELOPMENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SIMULIUM DAMNOSUM; SKIN BIOPSY; TREATMENT RESPONSE; WOLBACHIA; ANIMAL; CAMEROON; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN EXPERIMENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PARASITOLOGY; POLYMERASE CHAIN REACTION; SIMULIIDAE; TREATMENT OUTCOME;

ENDOBACTERIA; HEXAPODA; ONCHOCERCA VOLVULUS; SIMULIUM DAMNOSUM; WOLBACHIA;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; CAMEROON; DNA, BACTERIAL; DOXYCYCLINE; HUMAN EXPERIMENTATION; HUMANS; LARVA; MALE; MIDDLE AGED; ONCHOCERCA VOLVULUS; POLYMERASE CHAIN REACTION; SIMULIIDAE; TREATMENT OUTCOME; WOLBACHIA; YOUNG ADULT;

EID: 84855602266     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-5-12     Document Type: Article

References (36)

1. Control of onchocerciasis. Boatin BA, Richards FO Jr, Adv Parasitol 2006 61 349 394 16735169 (Pubitemid 43792518)
2. Onchocerciasis (River Blindness). WHO, WHO Fact Sheet 2000 95
3. River Blindness: A success story under threat? Basãez MG, Pion SD, Churcher TS, Breitling L, Little MP, Boussinesq M, PLoS Med 2006 3
4. Meeting of the International Task Force for Disease Eradication - 11 January 2007. WHO, Wkly Epidemiol Rec 2007 82 197 202 17542091
5. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Trans R SocTrop Med Hyg 1999 93 189 194 10.1016/S0035-9203(99)90305-X (Pubitemid 29233861)
6. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, Ahmed K, Boatin BA, Boakye DA, Edwards G, Ann Trop Med Parasitol 2004 98 359 370 10.1179/000349804225003442 15228717 (Pubitemid 38903480)
7. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, Lazdins-Helds JK, Ardrey AE, Addy ET, Quartey BT, Ahmed K, Boatin BA, Soumbey-Alley EW, Ann Trop Med Parasitol 2004 98 231 249 10.1179/000349804225003253 15119969 (Pubitemid 38594732)
8. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, Prichard RK, PLoS Negl Trop Dis 2011 5 998 10.1371/journal.pntd.0000998 21468315
9. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK, Lancet 2007 369 2021 2029 10.1016/S0140-6736(07)60942-8 17574093 (Pubitemid 46899181)
10. Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Taylor MJ, Awadzi K, Basanez MG, Biritwum N, Boakye D, Boatin B, Bockarie M, Churcher TS, Debrah A, Edwards G, Hoerauf A, Mand S, Matthews G, Osei-Atweneboana M, Prichard RK, Wanji S, Adjei O, Parasit Vectors 2009 2 7 10.1186/1756-3305-2-7 19154624
11. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner D, Lancet 2001 357 1415 1416 10.1016/S0140-6736(00) 04581-5 11356444 (Pubitemid 32455374)
12. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Büttner DW, Microbes Infect 2003 5 261 273 10.1016/S1286-4579(03)00026-1 12706439 (Pubitemid 36428715)
13. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Hoerauf A, Specht S, Büttner M, Pfarr K, Mand S, Fimmers R, Marfo-Debrekyei Y, Konadu P, Debrah AY, Bandi C, Brattig N, Larbi J, Batsa L, Adjei O, Büttner DW, Med Microbiol Immunol 2008 197 295 311 10.1007/s00430-007-0062-1 17999080
14. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, McGarry HF, Adjei O, Taylor MJ, Hoerauf A, Clin Infect Dis 2006 42 1081 1089 10.1086/501351 16575724
15. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C, Fimmers R, Adjei O, Büttner DW, Parasitol Res 2009 104 437 447 10.1007/s00436-008-1217-8 18850111
16. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, Faragher B, Specht S, Mand S, Hoerauf A, Enyong P, Wanji S, Taylor MJ, PLoS Negl Trop Dis 2010 4 660 10.1371/journal.pntd.0000660 20405054
17. Infection of the intermediate mite host with Wolbachia-depleted Litomosoides sigmodontis microfilariae: Impaired L1 to L3 development and subsequent sex-ratio distortion in adult worms. Arumugam S, Pfarr KM, Hoerauf A, Int J Parasitol 2008 38 981 987 10.1016/j.ijpara.2007.12.006 18282572
18. Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unquiculatus). Bosshardt SC, McCall JW, Coleman SU, Jones KL, Petit TA, Klei TR, J Parasitol 1993 79 775 777 10.2307/3283620 8410553 (Pubitemid 23333673)
19. Tetracycline treatment and sex-ratio distortion: a role for Wolbachia in the moulting of filarial nematodes? Casiraghi M, McCall JW, Simoncini L, Kramer LH, Sacchi L, Genchi C, Werren JH, Bandi C, Int J Parasitol 2002 32 1457 1468 10.1016/S0020-7519(02)00158-3 12392911 (Pubitemid 35246512)
20. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro. Smith HL, Rajan TV, Exp Parasitol 2000 95 265 270 10.1006/expr.2000.4525 11038309
21. Primer3 on the WWW for general users and for biologist programmers. Rozen S, Skaletsky H, Meth Mol Biol 2000 132 365 386
22. Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). Gilbert J, Nfon CK, Makepeace BL, Njongmeta LM, Hastings IM, Pfarr KM, Renz A, Tanya VN, Trees AJ, J Infect Dis 2005 192 1483 1493 10.1086/462426 16170768 (Pubitemid 41401164)
23. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. Meijerink J, Mandigers C, van de Locht L, Tonnissen E, Goodsaid F, Raemaekers J, J Mol Diag 2001 3 55 61 10.1016/S1525-1578(10)60652-6 (Pubitemid 32440243)
24. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. Hoerauf A, Nissen-Pähle K, Schmetz C, Henkle-Dührsen K, Blaxter ML, Büttner DW, Gallin MY, Al-Qaoud KM, Lucius R, Fleischer B, J Clin Invest 1999 103 11 18 10.1172/JCI4768 9884329 (Pubitemid 29031158)
25. Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline teatment. Chirgwin SR, Nowling JM, Coleman SU, Klei TR, Exp Parasitol 2003 103 16 26 10.1016/S0014-4894(03)00063-8 12810042 (Pubitemid 37329353)
26. CCL17 controls mast cells for the defense against filarial larval entry. Specht S, Frank JK, Alferink J, Dubben B, Layland LE, Denece G, Bain O, Forster I, Kirschning CJ, Martin C, Hoerauf A, J Immunol 2011 186 4845 4852 10.4049/jimmunol.1000612 21398605
27. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits responses through TLR2 and TLR4. Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Büttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A, J Immunol 2004 173 437 445 15210803 (Pubitemid 38797370)
28. Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes. Johnston KL, Wu B, Guimaraes A, Ford L, Slatko BE, Taylor MJ, Parasit Vectors 2010 3 99 10.1186/1756-3305-3-99 20946650
29. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, Wu B, Graham M, Sharpley F, Slatko B, Pearlman E, Taylor MJ, J Biol Chem 2009 284 22364 22378 10.1074/jbc.M901528200 19458089
30. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ, Clin Microbiol Rev 2011 24 459 468 10.1128/CMR.00057-10 21734243
31. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Brattig NW, Büttner DW, Hoerauf A, Microbes Infect 2001 3 439 446 10.1016/S1286-4579(01)01399-5 11377205 (Pubitemid 32497272)
32. Temporal recruitment of neutrophils and eosinophils to the skin in a murine model for onchocercal dermatitis. Pearlman E, Garhart CA, Grand DJ, Diaconu E, Strine ER, Hall LR, Am J Trop Med Hyg 1999 61 14 18 10432048 (Pubitemid 29344980)
33. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Saint André A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, Volkmann L, Taylor MJ, Ford L, Hise AG, Lass JH, Diaconu E, Pearlman E, Science 2002 295 1892 1895 10.1126/science.1068732 11884755 (Pubitemid 34214126)
34. The development of Onchocerca ochengi (nematoda: filariodea) to the infective stage in Simulium damnosum s.l. with a note on the histochemical staining of the parasite. Omar MS, Denke AM, Raybould JN, Tropenmed Parasitol 1979 30 157 162 90413 (Pubitemid 9196680)
35. Effects of temperature on development of Onchocerca volvulus in Simulium ochraceum, and longevity of the simuliid vector. Takaoka H, Ochoa JO, Juarez EL, Hansen KM, J Parasitol 1982 68 478 483 10.2307/3280961 7097444 (Pubitemid 13237737)
36. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW, Parasit Vectors 2009 2 39 10.1186/1756-3305-2-39 19712455